Researchers examined the range of patient experiences with psoriasis and psoriatic arthritis to inform gaps in patient-centered care.
Investigators assessed the risk for atrial fibrillation and major adverse cardiovascular events potentially related to using ustekinumab vs tumor necrosis factor inhibitors in patients with psoriasis or psoriatic arthritis.
A high prevalence of CVD-related risk factors was observed in a cohort of patients with psoriatic arthritis.
Researchers examined factors associated with patient‐physician discordance in a cohort of patients with psoriatic arthritis.
Researchers identified a panel of 4 biomarkers that provide additional discriminatory value to that provided by age and sex alone in distinguishing psoriatic arthritis from osteoarthritis.
Researchers evaluated the prevalence of clinical and ultrasonographic entheseal involvement in patients with psoriatic arthritis, psoriasis, and fibromyalgia.
Investigators assessed the risk for herpes zoster and provided recommendations regarding treatment in patients with psoriasis.
Data from the Nurses’ Health Study II were used to assess the relationship between pro-inflammatory diet and psoriasis, psoriatic arthritis, and atopic dermatitis.
Anti-TNF-α agents have the same efficacy as ustekinumab, secukinumab, and ixekizumab in terms of dactylitis and enthesitis resolution.
Elevated C-reactive protein levels at baseline were associated with greater structural progression in psoriatic arthritis.